NCT00386906View on ClinicalTrials.gov

Sentinel Lymph Node (SLN) Biopsy for Conjunctival/Eyelid Melanoma

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

May 30, 2000

Primary Completion Date

September 28, 2023

Study Completion Date

September 28, 2023

Conditions
Eye DiseaseMelanoma
Interventions
PROCEDURE

Sentinel Lymph Node Mapping and Biopsy

Intraoperative lymphatic mapping, then biopsy/removal of the conjunctiva/eyelid tumor.

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT00386906 - Sentinel Lymph Node (SLN) Biopsy for Conjunctival/Eyelid Melanoma | Biotech Hunter | Biotech Hunter